Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-043559
Filing Date
2024-05-15
Accepted
2024-05-15 16:01:18
Documents
78
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205774-10q_vaso.htm   iXBRL 10-Q 618808
2 CERTIFICATION ea020577401ex31_vaso.htm EX-31 19479
3 CERTIFICATION ea020577401ex32_vaso.htm EX-32 7354
4 GRAPHIC image_001.jpg GRAPHIC 2766
  Complete submission text file 0001213900-24-043559.txt   4929419

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vaso-20240331.xsd EX-101.SCH 59719
6 XBRL CALCULATION FILE vaso-20240331_cal.xml EX-101.CAL 47340
7 XBRL DEFINITION FILE vaso-20240331_def.xml EX-101.DEF 244274
8 XBRL LABEL FILE vaso-20240331_lab.xml EX-101.LAB 459325
9 XBRL PRESENTATION FILE vaso-20240331_pre.xml EX-101.PRE 257444
82 EXTRACTED XBRL INSTANCE DOCUMENT ea0205774-10q_vaso_htm.xml XML 630986
Mailing Address 137 COMMERCIAL STREET, STE. 200 PLAINVIEW NY 11803
Business Address 137 COMMERCIAL STREET, STE. 200 PLAINVIEW NY 11803 516-997-4600
VASO Corp (Filer) CIK: 0000839087 (see all company filings)

EIN.: 112871434 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-18105 | Film No.: 24950128
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)